Abstract
Rupture of an atherosclerotic plaque exposes a thrombogenic matrix, which instantly triggers platelet tethering and activation. We here delineate the sequence of events during arterial thrombus formation and dissect the specific role of the various platelet receptors in this process. We also discuss the interplay of platelets with circulating immune cells, which support arterial thrombosis by fibrin formation in a process that involves extracellular nucleosomes. In the second part of this chapter we describe the role of platelets in atherosclerotic lesion formation. Platelets adhere to the dysfunctional endothelium early during atherogenesis. They contain a large machinery of proinflammatory molecules, which can be released upon their activation. This prepares the ground for subsequent leukocyte recruitment and infiltration, and boosts the inflammatory process of the arterial wall. Together, platelets play a critical role in both acute and chronic processes of the vascular wall, which makes them an attractive target for pharmacological strategies to treat arterial thrombosis and, potentially, also atheroprogression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD (2000) The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 86:131–138
Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR (2002) Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106:896–899
Bennett JS (2005) Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 115:3363–3369
Bennett JS, Chan C, Vilaire G, Mousa SA, DeGrado WF (1997) Agonist-activated alphavbeta3 on platelets and lymphocytes binds to the matrix protein osteopontin. J Biol Chem 272:8137–8140
Bergmeier W, Piffath CL, Goerge T et al (2006) The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci USA 103:16900–16905
Bertrand ME, Legrand V, Boland J et al (1998) Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation 98:1597–1603
Boilard E, Nigrovic PA, Larabee K et al (2010) Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327:580–583
Boisvert WA, Rose DM, Johnson KA et al (2006) Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol 168:1385–1395
Bombeli T, Schwartz BR, Harlan JM (1998) Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 187:329–339
Busse R, Fleming I, Hecker M (1993) Signal transduction in endothelium-dependent vasodilatation. Eur Heart J 14(Suppl I):2–9
Cabeza N, Li Z, Schulz C et al (2004) Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 53:2117–2121
Chatterjee M Blood. 2011 Apr 7;117(14):3907–11. PMID: 21330475
Choi WS, Jeon OH, Kim DS (2010) CD40 ligand shedding is regulated by interaction between matrix metalloproteinase-2 and platelet integrin alpha(IIb)beta(3). J Thromb Haemost 8:1364–1371
Clemetson KJ, Clemetson JM (2001) Platelet collagen receptors. Thromb Haemost 86:189–197
Coppinger JA, O’Connor R, Wynne K et al (2007) Moderation of the platelet releasate response by aspirin. Blood 109:4786–4792
Cottone S, Mule G, Nardi E et al (2007) Microalbuminuria and early endothelial activation in essential hypertension. J Hum Hypertens 21:167–172
Cybulsky MI, Gimbrone MA Jr (1991) Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788–791
De Meyer GR, Hoylaerts MF, Kockx MM, Yamamoto H, Herman AG, Bult H (1999) Intimal deposition of functional von Willebrand factor in atherogenesis. Arterioscler Thromb Vasc Biol 19:2524–2534
Denis MM, Tolley ND, Bunting M et al (2005) Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 122:379–391
Dietrich T, Perlitz C, Licha K et al (2007) ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions. Basic Res Cardiol 102:298–307
Dubois C, Panicot-Dubois L, Gainor JF, Furie BC, Furie B (2007) Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model. J Clin Invest 117:953–960
Dumont B, Lasne D, Rothschild C et al (2009) Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood 114:1900–1903
Feinberg MW, Jain MK, Werner F et al (2000) Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem 275:25766–25773
Fernandez-Ortiz A, Badimon JJ, Falk E et al (1994) Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 23:1562–1569
Frenette PS, Johnson RC, Hynes RO, Wagner DD (1995) Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 92:7450–7454
Fuchs TA, Brill A, Duerschmied D et al (2010) Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 107:15880–15885
Furie B, Furie BC (2007) In vivo thrombus formation. J Thromb Haemost 5(Suppl 1):12–17
Furie B, Furie BC (2008) Mechanisms of thrombus formation. N Engl J Med 359:938–949
Furman MI, Krueger LA, Linden MD, Barnard MR, Frelinger AL 3rd, Michelson AD (2004) Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. J Am Coll Cardiol 43:2319–2325
Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P (1995) Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci 748:501–507
Galkina E, Ley K (2007) Leukocyte influx in atherosclerosis. Curr Drug Targets 8:1239–1248
Gasic GJ, Gasic TB, Stewart CC (1968) Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 61:46–52
Gawaz M, Neumann FJ, Dickfeld T et al (1997) Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation 96:1809–1818
Gawaz M, Neumann FJ, Dickfeld T et al (1998) Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 98:1164–1171
Gawaz M, Brand K, Dickfeld T et al (2000) Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 148:75–85
Gawaz M, Page S, Massberg S et al (2002) Transient platelet interaction induces MCP-1 production by endothelial cells via I kappa B kinase complex activation. Thromb Haemost 88:307–314
Gibbins JM, Okuma M, Farndale R, Barnes M, Watson SP (1997) Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain. FEBS Lett 413:255–259
Gresele P, Falcinelli E, Loffredo F et al (2011) Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. Eur Heart J 32:316–325
Guyton JR, Klemp KF (1996) Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 16:4–11
Heeschen C, Dimmeler S, Hamm CW et al (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348:1104–1111
Henn V, Slupsky JR, Grafe M et al (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591–594
Holbrook LM, Watkins NA, Simmonds AD, Jones CI, Ouwehand WH, Gibbins JM (2010) Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation. Br J Haematol 148:627–637
Holtkotter O, Nieswandt B, Smyth N et al (2002) Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 277:10789–10794
Hristov M, Zernecke A, Bidzhekov K et al (2007) Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 100:590–597
Huo Y, Schober A, Forlow SB et al (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9:61–67
Italiano JE Jr, Richardson JL, Patel-Hett S et al (2008) Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111:1227–1233
Jandrot-Perrus M, Busfield S, Lagrue AH et al (2000) Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 96:1798–1807
Jasuja R, Furie B, Furie BC (2010) Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo. Blood 116:4665–4674
Jung SM, Moroi M (1998) Platelets interact with soluble and insoluble collagens through characteristically different reactions. J Biol Chem 273:14827–14837
Jurk K, Clemetson KJ, de Groot PG et al (2003) Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor. FASEB J 17:1490–1492
Kamykowski J, Carlton P, Sehgal S, Storrie B (2011) Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet {alpha}-granules. Blood 118:1370–1373
Kasirer-Friede A, Ware J, Leng L, Marchese P, Ruggeri ZM, Shattil SJ (2002) Lateral clustering of platelet GP Ib-IX complexes leads to up-regulation of the adhesive function of integrin alpha IIbbeta 3. J Biol Chem 277:11949–11956
Kasper B, Brandt E, Bulfone-Paus S, Petersen F (2004) Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase. Blood 103:1602–1610
Katsuda S, Kaji T (2003) Atherosclerosis and extracellular matrix. J Atheroscler Thromb 10:267–274
Kissel K, Berber S, Nockher A, Santoso S, Bein G, Hackstein H (2006) Human platelets target dendritic cell differentiation and production of proinflammatory cytokines. Transfusion 46:818–827
Klinger MH, Jelkmann W (2002) Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22:913–922
Koenen RR, von Hundelshausen P, Nesmelova IV et al (2009) Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 15:97–103
Kuijper PH, Gallardo Torres HI, Houben LA, Lammers JW, Zwaginga JJ, Koenderman L (1998) P-selectin and MAC-1 mediate monocyte rolling and adhesion to ECM-bound platelets under flow conditions. J Leukoc Biol 64:467–73
Kuijpers MJ, Schulte V, Bergmeier W et al (2003) Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo. FASEB J 17:685–687
Kuijpers MJ, Pozgajova M, Cosemans JM et al (2007) Role of murine integrin alpha2beta1 in thrombus stabilization and embolization: contribution of thromboxane A2. Thromb Haemost 98:1072–1080
Kuijpers MJ, Gilio K, Reitsma S et al (2009) Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital model. J Thromb Haemost 7:152–161
Langer HF, Daub K, Braun G et al (2007) Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol 27:1463–1470
Leon MB, Baim DS, Popma JJ et al (1998) A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 339:1665–1671
Levi M (2005) Platelets in sepsis. Hematology 10(Suppl 1):129–131
Li G, Sanders JM, Bevard MH et al (2008) CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury. Am J Pathol 172:1141–1152
Lievens D, Zernecke A, Seijkens T et al (2010) Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 116:4317–4327
Lindemann S, Tolley ND, Dixon DA et al (2001) Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 154:485–490
Lusis AJ (2000) Atherosclerosis. Nature 407:233–241
Mackman N (2004) Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24:1015–1022
Mailhac A, Badimon JJ, Fallon JT et al (1994) Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation 90:988–996
Massberg S, Enders G, Leiderer R et al (1998) Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 92:507–515
Massberg S, Brand K, Gruner S et al (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196:887–896
Massberg S, Gawaz M, Gruner S et al (2003) A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197:41–49
Massberg S, Konrad I, Bultmann A et al (2004) Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 18:397–399
Massberg S, Schurzinger K, Lorenz M et al (2005) Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112:1180–1188
Massberg S, Konrad I, Schurzinger K et al (2006) Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 203:1221–1233
Massberg S, Grahl L, von Bruehl ML et al (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 16:887–896
May AE, Kalsch T, Massberg S, Herouy Y, Schmidt R, Gawaz M (2002) Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 106:2111–2117
Maynard DM, Heijnen HF, Horne MK, White JG, Gahl WA (2007) Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 5:1945–1955
Meyer dos Santos S, Klinkhardt U, Scholich K et al (2011) The CX3C chemokine fractalkine mediates platelet adhesion via the von Willebrand receptor glycoprotein Ib. Blood 117:4999–5008
Miller DL, Yaron R, Yellin MJ (1998) CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J Leukoc Biol 63:373–379
Moroi M, Jung SM, Okuma M, Shinmyozu K (1989a) A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 84:1440–1445
Moroi M, Jung SM, Okuma M, Shinmyozu K (1989b) A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 84:1440–1445
Moroi M, Jung SM, Shinmyozu K, Tomiyama Y, Ordinas A, Diaz-Ricart M (1996) Analysis of platelet adhesion to a collagen-coated surface under flow conditions: the involvement of glycoprotein VI in the platelet adhesion. Blood 88:2081–2092
Nesbitt WS, Westein E, Tovar-Lopez FJ et al (2009) A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 15:665–673
Nieswandt B, Watson SP (2003) Platelet-collagen interaction: is GPVI the central receptor? Blood 102:449–461
Nieswandt B, Brakebusch C, Bergmeier W et al (2001) Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 20:2120–2130
Nieswandt B, Pleines I, Bender M (2011) Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost 9(Suppl 1):92–104
Offermanns S (2006) Activation of platelet function through G protein-coupled receptors. Circ Res 99:1293–1304
Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C (2002) JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 3:151–158
Penz S, Reininger AJ, Brandl R et al (2005) Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 19:898–909
Pitsilos S, Hunt J, Mohler ER et al (2003) Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost 90:1112–1120
Radomski MW, Palmer RM, Moncada S (1987) The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 92:639–646
Reinhardt C, von Bruhl ML, Manukyan D et al (2008) Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest 118:1110–1122
Reininger AJ, Heijnen HF, Schumann H, Specht HM, Schramm W, Ruggeri ZM (2006) Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 107:3537–3545
Reininger AJ, Bernlochner I, Penz SM et al (2010) A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. J Am Coll Cardiol 55:1147–1158
Reynolds LE, Wyder L, Lively JC et al (2002) Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 8:27–34
Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR (1991) Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 78:1760–1769
Romo GM, Dong JF, Schade AJ et al (1999) The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 190:803–814
Rosenblum WI, Nelson GH, Wormley B, Werner P, Wang J, Shih CC (1996) Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo. Stroke 27:709–711
Ross R (1999) Atherosclerosis–an inflammatory disease. N Engl J Med 340:115–126
Ruggeri ZM (2004) Platelet and von Willebrand factor interactions at the vessel wall. Hämostaseologie 24:1–11
Ruggeri ZM (2007) The role of von Willebrand factor in thrombus formation. Thromb Res 120(Suppl 1):S5–S9
Salles II, Feys HB, Iserbyt BF, De Meyer SF, Vanhoorelbeke K, Deckmyn H (2008) Inherited traits affecting platelet function. Blood Rev 22:155–172
Savage B, Saldivar E, Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84:289–297
Sawicki G, Sanders EJ, Salas E, Wozniak M, Rodrigo J, Radomski MW (1998) Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost 80:836–839
Schmidt R, Bultmann A, Fischel S et al (2008) Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes. Circ Res 102:302–309
Schober A, Manka D, von Hundelshausen P et al (2002) Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 106:1523–1529
Schomig A, Neumann FJ, Kastrati A et al (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084–1089
Schonberger T, Siegel-Axel D, Bussl R et al (2008) The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- mice. Cardiovasc Res 80:131–137
Schulte V, Snell D, Bergmeier W, Zirngibl H, Watson SP, Nieswandt B (2001) Evidence for two distinct epitopes within collagen for activation of murine platelets. J Biol Chem 276:364–368
Schulz C, Schafer A, Stolla M et al (2007) Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation 116:764–773
Schulz C, Penz S, Hoffmann C et al (2008a) Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 103:356–367
Schulz C, Konrad I, Sauer S et al (2008b) Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo. Thromb Haemost 99:190–195
Schulz C, Leuschen NV, Frohlich T et al (2010) Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood 115:4102–4110
Schulz C, von Bruhl ML, Barocke V et al (2011) EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall. J Thromb Haemost 9:1007–1019
Sehgal S, Storrie B (2007) Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost 5:2009–2016
Seizer P, Schiemann S, Merz T et al (2010) CD36 and macrophage scavenger receptor a modulate foam cell formation via inhibition of lipid-laden platelet phagocytosis. Semin Thromb Hemost 36:157–162
Semple JW, Italiano JE Jr, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11:264–274
Shpilberg O, Rabi I, Schiller K et al (2002) Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis. Circulation 105:1044–1048
Siess W, Zangl KJ, Essler M et al (1999) Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 96:6931–6936
Siwik DA, Chang DL, Colucci WS (2000) Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86:1259–1265
Slupsky JR, Kalbas M, Willuweit A, Henn V, Kroczek RA, Muller-Berghaus G (1998) Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 80:1008–1014
Smyth SS, McEver RP, Weyrich AS et al (2009) Platelet functions beyond hemostasis. J Thromb Haemost 7:1759–1766
Strony J, Beaudoin A, Brands D, Adelman B (1993) Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am J Physiol 265:H1787–H1796
Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H (1987) A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 69:1712–1720
Sugiyama T, Ishibashi T, Okuma M (1993) Functional role of the antigen recognized by an antiplatelet antibody specific for a putative collagen receptor in platelet-collagen interaction. Int J Hematol 58:99–104
Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S (2003) New markers of inflammation and endothelial cell activation: Part I. Circulation 108:1917–1923
Ungerer M, Rosport K, Bultmann A et al (2011) Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation 123:1891–1899
Urban P, Macaya C, Rupprecht HJ et al (1998) Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Circulation 98:2126–2132
von Hundelshausen P, Weber KS, Huo Y et al (2001) RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103:1772–1777
von Hundelshausen P, Koenen RR, Sack M et al (2005) Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105:924–930
von Hundelshausen P, Koenen RR, Weber C (2009) Platelet-mediated enhancement of leukocyte adhesion. Microcirculation 16:84–96
Wagner DD, Frenette PS (2008) The vessel wall and its interactions. Blood 111:5271–5281
Wagner CL et al (1996) Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 88(3):907–914
Weng S, Zemany L, Standley KN et al (2003) Beta3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice. Proc Natl Acad Sci USA 100:6730–6735
Zarbock A, Singbartl K, Ley K (2006a) Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 116:3211–3219
Zarbock A, Singbartl K, Ley K (2006b) Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 116:3211–3219
Zarbock A, Polanowska-Grabowska RK, Ley K (2007) Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev 21:99–111
Zhang W, Li YS, Nardi MA et al (2010) Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombus. Blood 116:2336–2344
Zheng YM, Liu C, Chen H, Locke D, Ryan JC, Kahn ML (2001) Expression of the platelet receptor GPVI confers signaling via the Fc receptor gamma -chain in response to the snake venom convulxin but not to collagen. J Biol Chem 276:12999–13006
Zibara K, Chignier E, Covacho C et al (2000) Modulation of expression of endothelial intercellular adhesion molecule-1, platelet-endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1 in aortic arch lesions of apolipoprotein E-deficient compared with wild-type mice. Arterioscler Thromb Vasc Biol 20:2288–2296
Zwaginga JJ, Torres HI, Lammers J, Sixma JJ, Koenderman L, Kuijper PH (1999) Minimal platelet deposition and activation in models of injured vessel wall ensure optimal neutrophil adhesion under flow conditions. Arterioscler Thromb Vasc Biol 19:1549–1554
Zwicker JI, Trenor CC 3rd, Furie BC, Furie B (2011) Tissue factor-bearing microparticles and thrombus formation. Arterioscler Thromb Vasc Biol 31:728–733
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schulz, C., Massberg, S. (2012). Platelets in Atherosclerosis and Thrombosis. In: Gresele, P., Born, G., Patrono, C., Page, C. (eds) Antiplatelet Agents. Handbook of Experimental Pharmacology, vol 210. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29423-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-29423-5_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29422-8
Online ISBN: 978-3-642-29423-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)